Common questions about Cambia (FAQ)
Q: Is Cambia used for treating an existing migraine or for preventing them?
A: Cambia is officially indicated only for the acute treatment of migraine attacks in adults. This means it is intended to be taken when a migraine is actively occurring. Regulatory documents confirm that it is not indicated for the prophylactic (preventive) therapy of migraine, and is not to be used in an ongoing, daily regimen.
Q: Is the liquid form of Cambia absorbed faster than diclofenac tablets?
A: Cambia is specifically formulated as a powder for oral solution to achieve fast absorption and an immediate-release characteristic. While official prescribing information confirms this design, it does not provide a direct clinical comparison to other oral diclofenac tablets.
Q: How quickly can someone expect to feel relief after taking Cambia?
A: As a rapid-release drug, Cambia is designed for quick absorption. The terminal half-life of unchanged diclofenac is approximately 2 hours. The exact time until an individual feels relief is not standardized on the label. However, the drug is a rapid-release formulation designed for quick therapeutic action.
Q: Is it better to take Cambia on an empty stomach or with food?
A: Official administration guidelines state that Cambia should be prepared and taken on an empty stomach. Taking the medication with food may result in a reduction in its overall effectiveness, as food can interfere with the drug's rapid absorption characteristics.
Q: Is there an increased risk of serious side effects, like heart attack or stroke, associated with Cambia use?
A: Regulatory documents carry a serious warning that the risk of cardiovascular thrombotic events (such as heart attack and stroke) may increase with the duration of use and increasing doses of NSAIDs, including Cambia. The risk is noted across patient groups, and the label emphasizes that this risk can increase with the duration of use and higher doses.
Q: What are the warning signs of a serious skin reaction that require stopping Cambia?
A: Patients should be alert for signs of serious skin reactions, such as skin rash, blisters, fever, or other signs of hypersensitivity like itching. The official patient information informs patients that they should stop the medication immediately and seek medical attention if a rash or blistering develops.
Q: Can Cambia cause elevated liver enzymes or liver problems?
A: Yes, NSAIDs like diclofenac can cause elevated liver enzymes and, in rare cases, severe hepatic reactions (liver problems), including liver failure and fatalities. This can potentially occur at any time during treatment. Because of this potential, liver function monitoring is noted as part of the overall clinical safety profile for this class of medicine.
Q: Does Cambia cause drowsiness or dizziness that could affect driving?
A: Official safety information lists dizziness as a common side effect and notes that drowsiness has also been reported in post-marketing experience with diclofenac. The official label specifies that if patients experience dizziness, drowsiness, or vision changes, they should avoid driving or operating machinery.
Q: Does the efficacy of Cambia change if taken at the very start of a migraine versus later on?
A: Cambia is indicated for the acute treatment of migraine attacks, which means it should be taken once the attack has started. Although its formulation is rapid-release for quick action, the regulatory label does not specifically provide comparative efficacy data based on the timing of administration relative to the onset or progression of the migraine event.
Q: What is the difference between Cambia (diclofenac potassium) and other forms of diclofenac, like diclofenac sodium?
A: Cambia is a specific formulation of diclofenac potassium powder for solution. The official label explicitly states that Cambia is not interchangeable with other oral diclofenac formulations, such as enteric-coated tablets or diclofenac sodium, even if they have the same milligram strength.
Q: What kind of studies support the effectiveness of Cambia for acute migraine treatment?
A: The effectiveness of Cambia for treating acute migraine was established in two randomized, double-blind, placebo-controlled trials. These studies evaluated patients who had a history of migraine with or without aura.
Q: Is Cambia effective for migraines that include an aura?
A: According to the official indications, Cambia is approved for the acute treatment of migraine attacks with or without aura in adults.
Q: Does Cambia interact with common over-the-counter cold or flu medications?
A: Many over-the-counter cold and flu medications contain other NSAIDs (like ibuprofen or naproxen). Official drug interaction information warns that taking Cambia alongside other NSAIDs is not generally recommended due to an increased risk of side effects, particularly gastrointestinal bleeding.
Q: Can Cambia be taken for tension headaches or other non-migraine headaches?
A: Cambia is indicated only for the acute treatment of migraine attacks in adults. The safety and effectiveness of this specific formulation for treating other types of headaches, such as tension headache, have not been established.
Q: How long does Cambia typically stay in your system after taking a dose?
A: Based on the drug's properties, the terminal half-life of unchanged diclofenac is approximately 2 hours. This is the time it takes for half of the drug to be eliminated from the body.
Q: Can Cambia be taken while breastfeeding?
A: Diclofenac, the active ingredient, is present in human milk. Due to the potential for serious adverse reactions in the infant, the official recommendation is that breastfeeding is not recommended during treatment with Cambia.
Q: What is the reason Cambia is not recommended for treating cluster headaches?
A: The official prescribing information notes that the safety and effectiveness of Cambia have not been established for cluster headache. It is therefore not an approved use.
Q: Is it true that taking Cambia too often can potentially make headaches worse?
A: Official safety information notes a risk of medication overuse headache (MOH) with acute migraine treatments like NSAIDs. Medication overuse headache is a condition where frequent use of acute pain medication is associated with a worsening of headache frequency or severity.
Q: Are there specific patient populations, like the elderly, who need to be extra cautious with Cambia?
A: Yes, elderly patients are at greater risk for developing serious adverse events, including serious gastrointestinal bleeding and ulcers, as well as serious cardiovascular thrombotic events, compared to younger patients.
Q: Is it normal if I feel a tingling sensation after taking Cambia?
A: While a tingling sensation (paresthesia) is not listed among the most common side effects, it is a nervous system disorder that has been reported in post-marketing experience with diclofenac.
Q: Can Cambia affect fertility or make it harder to get pregnant?
A: The regulatory label states that, based on the mechanism of action, the use of Cambia may delay or prevent the rupture of ovarian follicles, which is a known possibility with this class of medication.
